Added to YB: 2019-04-16
Pitch date: 2019-04-16
DTIL:US [bullish]
Precision BioSciences, Inc.
-97.93%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.
Market Cap
$177.0M
Pitch Price
$396.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.52
P/E
-2.57
EV/Sales
2.31
Sector
Biotechnology
Category
N/A
Show full summary:
PRECISION BIOSCIENCES INC COM DTIL:US
A summary for this pitch has not been created yet.
Read full article (0 min)